search
Back to results

Development of Simulated Hippotherapy System and Investigation of Its Effectiveness in Children With Cerebral Palsy

Primary Purpose

Cerebral Palsy

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Hippotherapy
Neurodevelopmental Therapy
Sponsored by
Marmara University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Cerebral Palsy focused on measuring Cerebral Palsy, Physiotherapy and Rehabilitation, Hippotherapy, Balance

Eligibility Criteria

5 Years - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria

  • Having a diagnosis of Spastic Cerebral Palsy,
  • Children aged between 5 - 18 years,
  • Gross motor functional level is I, II or III,
  • Independent seating
  • Walking at least 10 meters independently,
  • Can understand simple verbal instructions,
  • Those with a spasticity level less than 2 according to Modified Ashworth Scale ,
  • Having bilateral hip abduction enough to sit on the hippotherapy device,
  • Voluntary acceptance to participate in the study

Exclusion Criteria

  • Having hip dislocation,
  • Severe contracture or deformity,
  • Scoliosis (above 20 degrees),
  • Acute uncontrolled acute seizures,
  • Epilepsy,
  • Visual and auditory problems,
  • Injection of botulinum toxin in the last 6 months,
  • History of surgical operation such as muscle relaxation, tendon extension and selective dorsal rhizotomy in the last 6 months.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    Control Group

    Study Group

    Arm Description

    Participants in this group will receive only Neurodevelopmental therapy (NDT) based rehabilitation for 45 minutes in each session, twice a week, during 8 weeks, 16 sessions in total. Number of participants in this group is anticipated to be 20.

    After 16 sessions (8 weeks) of only Neurodevelopmental therapy (NDT) based rehabilitation, simulated hippotherapy treatment will be added to rehabilitation program of the same participants. Their NDT treatment will be reduced to 25 minutes whereas hippotherapy will be applied for 20 minutes in each session, 2 sessions a week, 8 weeks in total.

    Outcomes

    Primary Outcome Measures

    Change in functional level from baseline, week 8 and week 16
    Functional level will be defined with Gross Motor Functional Classification System (GMFCS). GMFCS defines movements such as sitting, walking and use of mobility devices. It provides a clear description of a child's current gross motor functional level. Level I can climb stairs without the use of a railing. Level II can walk in most settings and climb stairs holding onto a railing. Level III needs usage of a hand held mobility device, may climb stairs holding onto a railing with assistance. Level IV requires physical assistance or powered mobility in most settings. Level V children are transported in a manuel wheelchair in all settings, they are limited in their ability to maintain antigravity head and trunk postures and control leg and arm movements.
    Change in spasticity from baseline, week 8 and week 16
    Spasticity will be defined with Modified Ashworth Scale (MAS). The MAS measures resistance during passive soft-tissue stretching. Scoring: 0= normal tone. 1= slight increase in muscle tone, minimal resistance at the end of the range of motion (ROM) when the affected part(s) is moved in flexion or extension. 1+= slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder of the ROM. 2= more marked increase in muscle tone through most of the ROM, but affected part(s) easily moved. 3= considerable increase in muscle tone, passive movement difficult. 4= affected part(s) rigid in flexion or extension.
    Change in range of motion from baseline, week 8 and week 16
    Lower extremity Range of Motion (ROM) will be measured with universal goniometer.
    Change in gross motor functional level from baseline, week 8 and week 16
    Gross motor function will be assessed with Gross Motor Function Measure-88. It consists of 88 items and contains 5 subdivisions: (A) reaching and turning; (B) sitting; (C) crawling and notebook; (D) standing; (E) walking, running and jumping. The total score and the scores of each sub-section are calculated. In our study, sections B, D and E will be evaluated.
    Change in postural control from baseline, week 8 and week 16
    Trunk movements will be assessed with Trunk Impairment Scale (TIS). It will be used to evaluate the postural control. The scale is developed to evaluate the people with stroke and has been adapted and validated for the children with Cerebral Palsy (CP). The TIS assesses static and dynamic sitting balance and trunk coordination in a sitting position. The static subscale investigates the ability of the subject to maintain a sitting position with feet supported, while the legs are passively crossed, and when the subject crosses the legs actively. The dynamic subscale contains items on lateral flexion of the trunk and unilateral lifting of the hip. For each item, a 2, 3 or 4-point ordinal scale is used. On the static and dynamic sitting balance and coordination subscales the maximal scores that can be attained are 7, 10 and 6 points. The total score for TIS ranges between 0 for a minimal performance to 23 for a perfect performance.
    Change in functional independence from baseline, week 8 and week 16
    Functional Independence will be defined with The Functional Independence Measure for Children (WeeFim). WeeFim consists of 6 parts: self-care, sphincter control, mobility, locomotion, communication and social communication. Each item is scored from 1 to 7 depending on whether it receives help when performing the function, whether it is on time, or whether the auxiliary device is required. "1" means fully dependent, "7" means fully independent. According to this, the highest score a child can get is 126 and the lowest score is 18.
    Change in functional balance from baseline, week 8 and week 16
    Balance will be defined with Pediatrics Balance Scale (PDS). It is an assessment tool adapted from the Berg Balance Scale (BDS) to evaluate the functional balance of children in daily living activities. The scale consists of 14 chapters and each section is scored between 0 and 4; the highest score is 56. PDS is a high-reliability scale between groups and test re-testing in school-age children with mild to moderate motor impairment. The scale is valid in children with Cerebral Palsy.
    Change in soft tissue from baseline, week 8 and week 16
    Soft tissue assessment will assessed with Myoton® PRO device. It is an evidence-based device that evaluates the bio-mechanical properties of soft biological tissues in a non-invasive, objective, reliable, inexpensive, quick and easy manner. Myoton® PRO is used in studies to evaluate superficial skeletal muscles, connective tissues such as tendons and ligaments, and other soft tissues. It is a highly reliable method for assessing the tone, stiffness, elasticity of muscles.
    Change in walking from baseline, week 8 and week 16
    Walking analysis will be assessed with FreeMed® (Sensör Medica) which is a baropodometric platform. The software program can perform postural evaluation and bio-mechanical analysis. Dynamic analysis software program allows walking analysis. It documents the results in curves and graphics, podalic geometry, walking cycle, numerical values, combination of forces and videography and records in computer environment.
    Change in body balance change from baseline, week 8 and week 16
    Balance will be assessed with Pedalo® Balance Device. It will be used to evaluate the balance during sitting and standing positions. Pedalo® balance device has been developed to record the user's movements to provide information about the body's balance, response time and possible imbalances. Pedalo® is a device that provides performance improvement in terms of balance and coordination. The device not only measures the performance that appears, but also compares previous performances to allow the evaluation of all performances.

    Secondary Outcome Measures

    Full Information

    First Posted
    March 17, 2019
    Last Updated
    March 26, 2019
    Sponsor
    Marmara University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03889262
    Brief Title
    Development of Simulated Hippotherapy System and Investigation of Its Effectiveness in Children With Cerebral Palsy
    Official Title
    Development of Simulated Hippotherapy System and Investigation of Its Effectiveness in Children With Cerebral Palsy
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    March 2019
    Overall Recruitment Status
    Unknown status
    Study Start Date
    April 1, 2019 (Anticipated)
    Primary Completion Date
    September 20, 2019 (Anticipated)
    Study Completion Date
    September 20, 2019 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Marmara University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The purpose of this study is to develop a simulated hippotherapy system controlled by electromyography (EMG) signals and investigate its effectiveness in children with cerebral palsy. In order to investigate its effectiveness evaluation of gross motor functions, lower extremity joint movements, spasticity of the lower extremities, functional independence, body movements, sitting and standing balance, muscle tone, stiffness and elasticity level, analysis of the walking are planned.
    Detailed Description
    Hippotherapy is a therapeutic method in which a real horse is used for therapeutic purposes. It is widely used in many countries in the treatment of neuromuscular diseases (Multiple Sclerosis, stroke, Cerebral Palsy, etc.). Although the use of hippotherapy is widespread, many people can not reach and use this method effectively because of many reasons such as the high cost of caring, feeding, and sheltering horses or fear of people from horses. In recent years, hippotherapy simulation devices (mechanic and robotic horses) have been developed to overcome these problems. These devices aim to create the effects of hippotherapy on people by simulating a real horse's movement. The aim of this project is to develop and produce a simulated hippotherapy system, which can be controlled by electromyography (EMG) signals coming from the rider, movements programmable (for different musculoskeletal problems), rehabilitation-specific, providing evaluation during therapy, integrating virtual reality system and therapy games and investigate its effectiveness in children with cerebral palsy.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Cerebral Palsy
    Keywords
    Cerebral Palsy, Physiotherapy and Rehabilitation, Hippotherapy, Balance

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Not Applicable
    Interventional Study Model
    Crossover Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    20 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Control Group
    Arm Type
    Active Comparator
    Arm Description
    Participants in this group will receive only Neurodevelopmental therapy (NDT) based rehabilitation for 45 minutes in each session, twice a week, during 8 weeks, 16 sessions in total. Number of participants in this group is anticipated to be 20.
    Arm Title
    Study Group
    Arm Type
    Active Comparator
    Arm Description
    After 16 sessions (8 weeks) of only Neurodevelopmental therapy (NDT) based rehabilitation, simulated hippotherapy treatment will be added to rehabilitation program of the same participants. Their NDT treatment will be reduced to 25 minutes whereas hippotherapy will be applied for 20 minutes in each session, 2 sessions a week, 8 weeks in total.
    Intervention Type
    Other
    Intervention Name(s)
    Hippotherapy
    Intervention Description
    Hippotherapy is a therapeutic method in which a mechanical horse is used for therapeutic purposes.
    Intervention Type
    Other
    Intervention Name(s)
    Neurodevelopmental Therapy
    Other Intervention Name(s)
    Bobath Therapy
    Intervention Description
    Neurodevelopmental therapy (NDT) is a hands-on treatment approach used by physical therapists, occupational therapists, and speech-language pathologists. NDT was developed to enhance the function of children who have difficulty controlling movement as a result of neurological challenges, such as cerebral palsy and head injury. During treatment interventions, repeated experience in movement ensures that a particular pattern is readily accessible for motor performance. The more a patient performs certain movements, the easier these movements becomes.
    Primary Outcome Measure Information:
    Title
    Change in functional level from baseline, week 8 and week 16
    Description
    Functional level will be defined with Gross Motor Functional Classification System (GMFCS). GMFCS defines movements such as sitting, walking and use of mobility devices. It provides a clear description of a child's current gross motor functional level. Level I can climb stairs without the use of a railing. Level II can walk in most settings and climb stairs holding onto a railing. Level III needs usage of a hand held mobility device, may climb stairs holding onto a railing with assistance. Level IV requires physical assistance or powered mobility in most settings. Level V children are transported in a manuel wheelchair in all settings, they are limited in their ability to maintain antigravity head and trunk postures and control leg and arm movements.
    Time Frame
    16 weeks
    Title
    Change in spasticity from baseline, week 8 and week 16
    Description
    Spasticity will be defined with Modified Ashworth Scale (MAS). The MAS measures resistance during passive soft-tissue stretching. Scoring: 0= normal tone. 1= slight increase in muscle tone, minimal resistance at the end of the range of motion (ROM) when the affected part(s) is moved in flexion or extension. 1+= slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder of the ROM. 2= more marked increase in muscle tone through most of the ROM, but affected part(s) easily moved. 3= considerable increase in muscle tone, passive movement difficult. 4= affected part(s) rigid in flexion or extension.
    Time Frame
    16 weeks
    Title
    Change in range of motion from baseline, week 8 and week 16
    Description
    Lower extremity Range of Motion (ROM) will be measured with universal goniometer.
    Time Frame
    16 weeks
    Title
    Change in gross motor functional level from baseline, week 8 and week 16
    Description
    Gross motor function will be assessed with Gross Motor Function Measure-88. It consists of 88 items and contains 5 subdivisions: (A) reaching and turning; (B) sitting; (C) crawling and notebook; (D) standing; (E) walking, running and jumping. The total score and the scores of each sub-section are calculated. In our study, sections B, D and E will be evaluated.
    Time Frame
    16 weeks
    Title
    Change in postural control from baseline, week 8 and week 16
    Description
    Trunk movements will be assessed with Trunk Impairment Scale (TIS). It will be used to evaluate the postural control. The scale is developed to evaluate the people with stroke and has been adapted and validated for the children with Cerebral Palsy (CP). The TIS assesses static and dynamic sitting balance and trunk coordination in a sitting position. The static subscale investigates the ability of the subject to maintain a sitting position with feet supported, while the legs are passively crossed, and when the subject crosses the legs actively. The dynamic subscale contains items on lateral flexion of the trunk and unilateral lifting of the hip. For each item, a 2, 3 or 4-point ordinal scale is used. On the static and dynamic sitting balance and coordination subscales the maximal scores that can be attained are 7, 10 and 6 points. The total score for TIS ranges between 0 for a minimal performance to 23 for a perfect performance.
    Time Frame
    16 weeks
    Title
    Change in functional independence from baseline, week 8 and week 16
    Description
    Functional Independence will be defined with The Functional Independence Measure for Children (WeeFim). WeeFim consists of 6 parts: self-care, sphincter control, mobility, locomotion, communication and social communication. Each item is scored from 1 to 7 depending on whether it receives help when performing the function, whether it is on time, or whether the auxiliary device is required. "1" means fully dependent, "7" means fully independent. According to this, the highest score a child can get is 126 and the lowest score is 18.
    Time Frame
    16 weeks
    Title
    Change in functional balance from baseline, week 8 and week 16
    Description
    Balance will be defined with Pediatrics Balance Scale (PDS). It is an assessment tool adapted from the Berg Balance Scale (BDS) to evaluate the functional balance of children in daily living activities. The scale consists of 14 chapters and each section is scored between 0 and 4; the highest score is 56. PDS is a high-reliability scale between groups and test re-testing in school-age children with mild to moderate motor impairment. The scale is valid in children with Cerebral Palsy.
    Time Frame
    16 weeks
    Title
    Change in soft tissue from baseline, week 8 and week 16
    Description
    Soft tissue assessment will assessed with Myoton® PRO device. It is an evidence-based device that evaluates the bio-mechanical properties of soft biological tissues in a non-invasive, objective, reliable, inexpensive, quick and easy manner. Myoton® PRO is used in studies to evaluate superficial skeletal muscles, connective tissues such as tendons and ligaments, and other soft tissues. It is a highly reliable method for assessing the tone, stiffness, elasticity of muscles.
    Time Frame
    16 weeks
    Title
    Change in walking from baseline, week 8 and week 16
    Description
    Walking analysis will be assessed with FreeMed® (Sensör Medica) which is a baropodometric platform. The software program can perform postural evaluation and bio-mechanical analysis. Dynamic analysis software program allows walking analysis. It documents the results in curves and graphics, podalic geometry, walking cycle, numerical values, combination of forces and videography and records in computer environment.
    Time Frame
    16 weeks
    Title
    Change in body balance change from baseline, week 8 and week 16
    Description
    Balance will be assessed with Pedalo® Balance Device. It will be used to evaluate the balance during sitting and standing positions. Pedalo® balance device has been developed to record the user's movements to provide information about the body's balance, response time and possible imbalances. Pedalo® is a device that provides performance improvement in terms of balance and coordination. The device not only measures the performance that appears, but also compares previous performances to allow the evaluation of all performances.
    Time Frame
    16 weeks

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    5 Years
    Maximum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria Having a diagnosis of Spastic Cerebral Palsy, Children aged between 5 - 18 years, Gross motor functional level is I, II or III, Independent seating Walking at least 10 meters independently, Can understand simple verbal instructions, Those with a spasticity level less than 2 according to Modified Ashworth Scale , Having bilateral hip abduction enough to sit on the hippotherapy device, Voluntary acceptance to participate in the study Exclusion Criteria Having hip dislocation, Severe contracture or deformity, Scoliosis (above 20 degrees), Acute uncontrolled acute seizures, Epilepsy, Visual and auditory problems, Injection of botulinum toxin in the last 6 months, History of surgical operation such as muscle relaxation, tendon extension and selective dorsal rhizotomy in the last 6 months.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Neslihan Karabacak
    Phone
    +905347474980
    Email
    neslikarabacak@gmail.com
    First Name & Middle Initial & Last Name or Official Title & Degree
    Canan Günay Yazıcı
    Phone
    +905384601249
    Email
    cnngnyzc@gmail.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Zubeyir Sarı
    Organizational Affiliation
    Marmara University Institute of Health Sciences
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    IPD Sharing Plan Description
    Study protocol, statistical analysis plan, informed consent form, clinical study report might be considered to be shared with the clinicians studying in the same field one year after the publication of the study.
    Citations:
    PubMed Identifier
    26930110
    Citation
    Champagne D, Corriveau H, Dugas C. Effect of Hippotherapy on Motor Proficiency and Function in Children with Cerebral Palsy Who Walk. Phys Occup Ther Pediatr. 2017 Feb;37(1):51-63. doi: 10.3109/01942638.2015.1129386. Epub 2016 Mar 1.
    Results Reference
    background
    PubMed Identifier
    23342307
    Citation
    Han JY, Kim JM, Kim SK, Chung JS, Lee HC, Lim JK, Lee J, Park KY. Therapeutic effects of mechanical horseback riding on gait and balance ability in stroke patients. Ann Rehabil Med. 2012 Dec;36(6):762-9. doi: 10.5535/arm.2012.36.6.762. Epub 2012 Dec 28.
    Results Reference
    background
    PubMed Identifier
    22610128
    Citation
    Herrero P, Gomez-Trullen EM, Asensio A, Garcia E, Casas R, Monserrat E, Pandyan A. Study of the therapeutic effects of a hippotherapy simulator in children with cerebral palsy: a stratified single-blind randomized controlled trial. Clin Rehabil. 2012 Dec;26(12):1105-13. doi: 10.1177/0269215512444633. Epub 2012 May 18.
    Results Reference
    background
    PubMed Identifier
    20942267
    Citation
    Hosaka Y, Nagasaki M, Bajotto G, Shinomiya Y, Ozawa T, Sato Y. Effects of daily mechanical horseback riding on insulin sensitivity and resting metabolism in middle-aged type 2 diabetes mellitus patients. Nagoya J Med Sci. 2010 Aug;72(3-4):129-37.
    Results Reference
    background
    PubMed Identifier
    19011528
    Citation
    Glanzman AM, Swenson AE, Kim H. Intrarater range of motion reliability in cerebral palsy: a comparison of assessment methods. Pediatr Phys Ther. 2008 Winter;20(4):369-72. doi: 10.1097/PEP.0b013e31818b7994.
    Results Reference
    background
    PubMed Identifier
    17057441
    Citation
    Franjoine MR, Gunther JS, Taylor MJ. Pediatric balance scale: a modified version of the berg balance scale for the school-age child with mild to moderate motor impairment. Pediatr Phys Ther. 2003 Summer;15(2):114-28. doi: 10.1097/01.PEP.0000068117.48023.18.
    Results Reference
    background
    PubMed Identifier
    25465508
    Citation
    Kim SG, Lee JH. The effects of horse riding simulation exercise on muscle activation and limits of stability in the elderly. Arch Gerontol Geriatr. 2015 Jan-Feb;60(1):62-5. doi: 10.1016/j.archger.2014.10.018. Epub 2014 Nov 7.
    Results Reference
    background
    PubMed Identifier
    28533611
    Citation
    Kim SK, Kim SG, HwangBo G. The effect of horse-riding simulator exercise on the gait, muscle strength and muscle activation in elderly people with knee osteoarthritis. J Phys Ther Sci. 2017 Apr;29(4):693-696. doi: 10.1589/jpts.29.693. Epub 2017 Apr 20.
    Results Reference
    background
    PubMed Identifier
    11386402
    Citation
    Kucukdeveci AA, Yavuzer G, Elhan AH, Sonel B, Tennant A. Adaptation of the Functional Independence Measure for use in Turkey. Clin Rehabil. 2001 Jun;15(3):311-9. doi: 10.1191/026921501676877265.
    Results Reference
    background
    PubMed Identifier
    24707098
    Citation
    Lee CW, Kim SG, Na SS. The effects of hippotherapy and a horse riding simulator on the balance of children with cerebral palsy. J Phys Ther Sci. 2014 Mar;26(3):423-5. doi: 10.1589/jpts.26.423. Epub 2014 Mar 25.
    Results Reference
    background
    PubMed Identifier
    21876292
    Citation
    Lee DR, Lee NG, Cha HJ, Yun Sung O, You SJ, Oh JH, Bang HS. The effect of robo-horseback riding therapy on spinal alignment and associated muscle size in MRI for a child with neuromuscular scoliosis: an experimenter-blind study. NeuroRehabilitation. 2011;29(1):23-7. doi: 10.3233/NRE-2011-0673.
    Results Reference
    background
    PubMed Identifier
    28533630
    Citation
    Lee J, Yun CK. Effects of hippotherapy on the thickness of deep abdominal muscles and activity of daily living in children with intellectual disabilities. J Phys Ther Sci. 2017 Apr;29(4):779-782. doi: 10.1589/jpts.29.779. Epub 2017 Apr 20.
    Results Reference
    background
    PubMed Identifier
    28379061
    Citation
    Leveille A, Rochette A, Mainville C. Perceived risks and benefits of hippotherapy among parents of children currently engaged in or waiting for hippotherapy: A pilot study. Physiother Theory Pract. 2017 Apr;33(4):269-277. doi: 10.1080/09593985.2017.1302029. Epub 2017 Apr 5.
    Results Reference
    background
    PubMed Identifier
    17599027
    Citation
    Mutlu A, Livanelioglu A, Gunel MK. Reliability of goniometric measurements in children with spastic cerebral palsy. Med Sci Monit. 2007 Jul;13(7):CR323-9.
    Results Reference
    background
    PubMed Identifier
    18402701
    Citation
    Mutlu A, Livanelioglu A, Gunel MK. Reliability of Ashworth and Modified Ashworth scales in children with spastic cerebral palsy. BMC Musculoskelet Disord. 2008 Apr 10;9:44. doi: 10.1186/1471-2474-9-44.
    Results Reference
    background
    PubMed Identifier
    9183258
    Citation
    Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997 Apr;39(4):214-23. doi: 10.1111/j.1469-8749.1997.tb07414.x.
    Results Reference
    background
    PubMed Identifier
    25226963
    Citation
    Park JH, Shurtleff T, Engsberg J, Rafferty S, You JY, You IY, You SH. Comparison between the robo-horse and real horse movements for hippotherapy. Biomed Mater Eng. 2014;24(6):2603-10. doi: 10.3233/BME-141076.
    Results Reference
    background
    PubMed Identifier
    23643761
    Citation
    Saether R, Helbostad JL, Adde L, Jorgensen L, Vik T. Reliability and validity of the Trunk Impairment Scale in children and adolescents with cerebral palsy. Res Dev Disabil. 2013 Jul;34(7):2075-84. doi: 10.1016/j.ridd.2013.03.029. Epub 2013 May 1.
    Results Reference
    background
    PubMed Identifier
    22042184
    Citation
    Silva e Borges MB, Werneck MJ, da Silva Mde L, Gandolfi L, Pratesi R. Therapeutic effects of a horse riding simulator in children with cerebral palsy. Arq Neuropsiquiatr. 2011 Oct;69(5):799-804. doi: 10.1590/s0004-282x2011000600014.
    Results Reference
    background
    PubMed Identifier
    23011753
    Citation
    Yi SH, Hwang JH, Kim SJ, Kwon JY. Validity of pediatric balance scales in children with spastic cerebral palsy. Neuropediatrics. 2012 Dec;43(6):307-13. doi: 10.1055/s-0032-1327774. Epub 2012 Sep 25.
    Results Reference
    background

    Learn more about this trial

    Development of Simulated Hippotherapy System and Investigation of Its Effectiveness in Children With Cerebral Palsy

    We'll reach out to this number within 24 hrs